3Williams MP,Pounder RE.Review article the pharmacology of rabeprazole.Aliment Pharmacol Ther,1999,13(Suppl3):3 ～ 10.
4Hassan-Alin M,Andersson T,Bredberg E,et al.Pharmacoki-netics of esomeprazole after oral and intravenous administration of single and repeated doses to health subjects.Eur J Clin Pharmacol,2000,56:665 ～670.
5Castell DO,Fennerty MB,Johnson DA,et al.The critical analysis of new PPI esomeprazole.AGA New Drug Review,2001,1:1 ～ 19.
4Stedman CA, Barclay ML. Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Aliment Pharmacol Ther, 2000,14:963-978.
5Sachs G, Shin JM, Briving C, et al. The pharmacology of the gastric acid pump: the H+,K+ ATPase. Annu Rev Pharmacol Toxicol,1995,35:277-305.
7Besancon M, Simon A, Sachs G, et al. Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents. J Biol Chem,1997,272:22438-22446.
8BESANCON M, SIMON A, SACHS G, et al. Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents[J]. J Biol Chem, 1997,272(36):22438-22446.
9FIGALA V,KLEMM K ,KOHL B, et al .Acid activation of H,K-ATPase inhibiting 2(2-pyridylmethyl-sulphinyl)-benzimidazoles:isolation and its reactions[J]. J Chem Soc Chem Commun, 1996,20:125.
10BLUM RA. Lansoprazole and omeprazole in the treatmeat of acid peptic disorders[J]. Am J Health Syst Pharm, 1996,53(15):1401-1415.
